Alcon AG vs KLA Corp. — how do they compare? Alcon AG trades at $72.78 (market cap $36.44B), while KLA Corp. trades at $209 (market cap $261.92B). The key difference: KLA Corp. is far larger — about 7.2× Alcon AG's market cap, and Alcon AG pays the higher dividend (0.48%). Which is the better fit depends on your goals.
| ALC | KLAC | |
|---|---|---|
Market Cap | $36.44B | $261.92B |
Sector | Health | Technology |
52-Week High | $90.12 | $301.71 |
52-Week Low | $62.02 | $84.39 |
Enterprise Value | $40.28B | $263.17B |
Dividend Yield | 0.48% | 0.46% |
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →